Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation

Published:2014-10-21 Issue:12 Volume:27 Page:1253-1262
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Espigado Ildefonso¹²,de la Cruz-Vicente Fátima¹²,BenMarzouk-Hidalgo Omar J.¹³,Gracia-Ahufinger Irene¹³,Garcia-Lozano Jose R.¹⁴,Aguilar-Guisado Manuela¹³,Cisneros Jose M.¹³,Urbano-Ispizua Alvaro¹²,Perez-Romero Pilar¹³

Affiliation:

1. Instituto de Biomedicina de Sevilla (IBIS); Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla; Sevilla Spain

2. Clinical Hematology; Department of Hematology; Hospital Universitario Virgen del Rocio; Sevilla Spain

3. Unit of Infectious Disease, Microbiology, and Preventive Medicine; Hospital Universitario Virgen del Rocio; Sevilla Spain

4. Immunology Service; Hospital Universitario Virgen del Rocio; Sevilla Spain

Funder

Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria

Consejeria de Innovacion, Ciencia y Empresa

Junta de Andalucía

Ministerio de Sanidad y Consumo

Instituto de Salud Carlos III - FEDER

Spanish Network for the Research in Infectious Diseases

Spanish Network for the Research in Cancer

Instituto de Salud Carlos III

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12406/fullpdf

Reference40 articles.

1. CMV in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies;Boeckh;Biol Blood Marrow Transplant,2003

2. Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation;Gandhi;Blood,2003

3. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants;Rauser;Blood,2004

4. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation;Solano;J Clin Microbiol,2001

5. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc., Gaithersburg, Maryland;George;Am J Med,1997

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secretion of IFN-γ by specific T cells in HCMV infection;Heliyon;2024-03

2. QuantiFERON‐cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation;Transplant Infectious Disease;2022-01-25

3. Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity;eJHaem;2021-06

4. Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV;PLOS Pathogens;2020-07-15

5. CMV Specific T Cells for Treatment of CMV Infection After Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey;Turkish Journal of Hematology;2019-11-12